Strategies for the Treatment of Antipsychotic-Induced Sexual Dysfunction and/or Hyperprolactinemia Among Patients of the Schizophrenia Spectrum: A Review

@article{Nunes2012StrategiesFT,
  title={Strategies for the Treatment of Antipsychotic-Induced Sexual Dysfunction and/or Hyperprolactinemia Among Patients of the Schizophrenia Spectrum: A Review},
  author={Luciana Vargas Alves Nunes and H. Moreira and D. Razzouk and S. Nunes and J. Mari},
  journal={Journal of Sex & Marital Therapy},
  year={2012},
  volume={38},
  pages={281 - 301}
}
There is limited evidence for the management of sexual dysfunction and/or hyperprolactinemia resulting from use of antipsychotics in patients with schizophrenia and spectrum. The aim of this study was to review and describe the strategies for the treatment of antipsychotic-induced sexual dysfunctions and/or hyperprolactinemia. The research was carried out through Medline/PubMed, Cochrane, Lilacs, Embase, and PsycINFO, and it included open labels or randomized clinical trials. The authors found… Expand
View on Taylor & Francis
ncbi.nlm.nih.gov
38 Citations
Highly Influential Citations
3
Background Citations
14
Methods Citations
1

38 Citations

Citation Type

Citation Type

Adjunctive metformin for antipsychotic-induced hyperprolactinemia: A systematic review
  • 20
Management of Antipsychotic-Related Sexual Dysfunction: Systematic Review.
  • 5
Efficacy of tadalafil on erectile dysfunction in male patients using antipsychotics: a double-blind, placebo-controlled, crossover pilot study.
  • 12
Adjunctive metformin for antipsychotic-related hyperprolactinemia: A meta-analysis of randomized controlled trials
  • 12
Adjunctive treatment with lodenafil carbonate for erectile dysfunction in outpatients with schizophrenia and spectrum: a randomized, double-blind, crossover, placebo-controlled trial.
  • 12
  • PDF
Treating symptomatic hyperprolactinemia in women with schizophrenia: presentation of the ongoing DAAMSEL clinical trial (Dopamine partial Agonist, Aripiprazole, for the Management of Symptomatic ELevated prolactin)
  • 31
Sexual dysfunction related to psychotropic drugs: a critical review part II: antipsychotics.
  • 63
  • PDF
Add-on mirtazapine improves orgasmic functioning in patients with schizophrenia treated with first-generation antipsychotics
  • 8
  • PDF
ANTIPSYCHOTICS AND SEXUAL DYSFUNCTION: EPIDEMIOLOGY, MECHANISMS AND MANAGEMENT
  • 15
  • Highly Influenced
  • PDF
Management Strategies for Antipsychotic-Related Sexual Dysfunction: A Clinical Approach
  • PDF
...
1
2
3
4
...

References

SHOWING 1-10 OF 73 REFERENCES
A systematic review on clinical management of antipsychotic-induced sexual dysfunction in schizophrenia.
  • 38
  • PDF
An open-label trial of quetiapine for antipsychotic-induced sexual dysfunction
  • 21
Frequency of Sexual Dysfunction and Other Reproductive Side-effects in Patients with Schizophrenia Treated with Risperidone, Olanzapine, Quetiapine, or Haloperidol: The Results of the EIRE Study
  • 185
Change in sexual dysfunction with aripiprazole: a switching or add-on study
  • 73
A Randomized, Crossover Comparison of Herbal Medicine and Bromocriptine Against Risperidone-Induced Hyperprolactinemia in Patients With Schizophrenia
  • 62
Improvement in hyperprolactinemia and reproductive comorbidities in patients with schizophrenia switched from conventional antipsychotics or risperidone to olanzapine
  • 89
A systematic review of research on strategies for the management of antipsychotic-induced sexual dysfunction: high-level evidence is needed.
  • 6
Sildenafil in the treatment of antipsychotic-induced erectile dysfunction: a randomized, double-blind, placebo-controlled, flexible-dose, two-way crossover trial.
  • 71
  • Highly Influential
Cabergoline treatment of risperidone-induced hyperprolactinemia: a pilot study.
  • 62
Using aripiprazole to resolve antipsychotic-induced symptomatic hyperprolactinemia: A pilot study
  • 66
...
1
2
3
4
5
...